pharma prices price change drug price tender management government tenders government tendering drug price comparison reference pricing strategy reference price price performance
Complete the form
below to watch
A Recent European survey indicated that 87% of responding life Sciences companies see External reference pricing as key to competitive advantage but only 12% have adequate technology, processes and teams in place to gain competitive advantage.
Listen to Mark Hill from Gilead and James Robinson from Model N zoom in on some key best practices for successful launch sequencing and building a business case for a global pricing improvement program.